Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Secondary intraocular fixation: anterior vs. posterior segment approaches, middle segment surgery, and emerging artificial capsule technologies.
Journal: Current opinion in ophthalmology
Published: May 04, 2026
Retrospective Evaluation of Successive Biovance ® Decellularized Basement Membrane Tissue Grafts for the Management of Chronic Subclinical and Stage 1 Neurotrophic Keratitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 12, 2026
Using Lotilaner Ophthalmic Solution, 0.25% to Treat Demodex Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series.
Journal: Clinical optometry
Published: February 04, 2026
Lotilaner ophthalmic solution 0.25% in the treatment of Demodex blepharitis: A case report.
Journal: SAGE open medical case reports
Published: November 14, 2025
Complications of Epithelium-Off Crosslinking for Keratoconus: A Single Institution Historical Experience.
Journal: Journal of cataract and refractive surgery
Published: October 21, 2025
Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: July 28, 2025
The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 25, 2025
Corneal Tissue Addition Keratoplasty for the Treatment of Keratoconus: A Review.
Journal: International ophthalmology clinics
Published: March 21, 2025
Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty.
Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty.
Journal: Oman journal of ophthalmology
Published: September 30, 2024
A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter].
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 11, 2024
Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 16, 2024
Last Updated: 09/26/2026